Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Tumor Lysis Syndrome × Febuxostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Tumor Lysis Syndrome 1 Lymphoma 1 Leukemia 1 Inflammation 1 Hyperuricemia 1 Gout 1 Cardiovascular Diseases 1 Arthritis 1

Interventions

rasburicase 3 Urate Oxidase 3 Allopurinol 2 venetoclax 1 obinutuzumab 1 Lenalidomide 1 Febuxostat 1 Bendamustine Hydrochloride 1 AZD0466 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01724528 2014-11-03

FLORENCE

Menarini Group

Phase 3 Completed

346 enrolled 16 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Tumor Lysis Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡